がん領域におけるAI分析ソリューションの世界市場レポート 2025年

がん領域におけるAI分析ソリューション市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR34.1％で46億6,000万米ドルに成長します。予測期間の成長は、個別化医療への需要の高まり、ヘルスケア意識の高まり、マルチオミクスデータの統合、規制の洗練化、遠隔医療、遠隔診断に起因すると考えられます。予測期間における主な動向には、共同研究やパートナーシップ、継続的な技術進歩、業界連携、研究開発イニシアティブ、技術の進歩などがあります。

がん罹患率の増加ががん領域におけるAI分析ソリューション市場の拡大を牽引すると予想されます。がんは、異常細胞の制御不能な増殖と拡散を特徴とする疾患群です。がん領域におけるAI分析ソリューションは、大量の複雑なデータを迅速かつ効率的に処理する能力により、個別化治療、早期発見、患者の転帰改善を可能にすることで、がん治療において重要な役割を果たしています。例えば、2024年5月、米国の政府機関である国立がん研究所は、2024年に米国で新たに約200万人のがん患者が診断され、61万1000人以上のがん関連死が発生すると予測しました。2040年までには、世界の新規がん患者は2,990万人に増加し、がん関連死は1,530万人に達すると予想されています。その結果、がんの有病率の増加ががん領域におけるAI分析ソリューションの成長を牽引しています。

がん領域におけるAI分析ソリューション市場の有力企業は、がん研究を加速し、腫瘍学の生成AIモデルを強化するための新しい実世界データプラットフォームの開発など、AI技術の発展に注力しています。リアルワールドデータプラットフォームは、電子カルテ、健康保険請求、患者調査、疾患登録など、従来の臨床研究環境以外の多様なソースからの観察データを統合・管理します。例えば、2023年10月、米国のCentral Ohio Transit Authorityは、がん研究を迅速化し、腫瘍学におけるジェネレーティブAIモデルを強化するために設計された新しいリアルワールドデータプラットフォームであるVistaを立ち上げました。Vistaは、データポータルデータベースやゲノムデータベースを含む複数のデータベースを統合し、がん研究データを管理するための包括的かつ標準化されたアプローチを提供します。さらに、Vistaはデータ共有を促進し、データ品質を向上させ、腫瘍学やその他のヘルスケア領域における様々なアプリケーションをサポートすることが期待されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界がん領域におけるAI分析ソリューションPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のがん領域におけるAI分析ソリューション市場：成長率分析
• 世界のがん領域におけるAI分析ソリューション市場の実績：規模と成長, 2019-2024
• 世界のがん領域におけるAI分析ソリューション市場の予測：規模と成長, 2024-2029, 2034F
• 世界がん領域におけるAI分析ソリューション総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のがん領域におけるAI分析ソリューション市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• データライセンシングサービス
• ソフトウェアソリューション
• 分析およびその他のサービス
• 世界のがん領域におけるAI分析ソリューション市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 放射線治療
• 免疫療法
• その他の治療法
• 世界のがん領域におけるAI分析ソリューション市場がんの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳がん
• 肺がん
• 前立腺がん
• 大腸がん
• 脳腫瘍
• 腎臓がん
• 非ホジキンリンパ腫
• 膀胱がん
• 世界のがん領域におけるAI分析ソリューション市場データライセンシングサービスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学データライセンシング
• ゲノムデータのライセンシング
• 世界のがん領域におけるAI分析ソリューション市場ソフトウェアソリューションのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• AIベースの画像処理ソフトウェア
• 診断ソフトウェア
• 臨床意思決定支援ソフトウェア
• 世界のがん領域におけるAI分析ソリューション市場分析サービスとその他のサービスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 予測分析サービス
• AIトレーニングおよびサポートサービス
• データ分析サービス

第7章 地域別・国別分析

• 世界のがん領域におけるAI分析ソリューション市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のがん領域におけるAI分析ソリューション市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん領域におけるAI分析ソリューション市場：競合情勢
• がん領域におけるAI分析ソリューション市場：企業プロファイル
  • IBM Watson Health Overview, Products and Services, Strategy and Financial Analysis
  • NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Tempus Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• DeepMind Health
• Paige.AI
• PathAI
• Aidoc
• Nucleai
• HeartFlow
• OWKIN
• SOPHiA Genetics
• Imagen Technologies
• Butterfly Network
• Atomwise
• Enlitic
• Inspirata
• 3Scan
• Zebra Medical Vision

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• がん領域におけるAI分析ソリューション市場2029：新たな機会を提供する国
• がん領域におけるAI分析ソリューション市場2029：新たな機会を提供するセグメント
• がん領域におけるAI分析ソリューション市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

AI in oncology for analytical solutions involves the utilization of artificial intelligence (AI) technology within the oncology field to develop advanced analytical solutions for cancer research, diagnosis, and treatment. This technology aids healthcare professionals in making data-driven decisions, enhancing diagnostic accuracy, and customizing treatment plans.

The primary components in AI in oncology for analytical solutions include data licensing services, software solutions, analytics, and other related elements. Data licensing entails the process of granting or obtaining legal permission to utilize and access data, typically through a contractual agreement between the data provider (licensor) and the data user (licensee). These solutions encompass various treatment types such as chemotherapy, radiotherapy, immunotherapy, and others, catering to a wide array of cancer types including breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumors, kidney cancer, non-Hodgkin lymphoma, and bladder cancer.

The AI in oncology for analytical solutions market research report is one of a series of new reports from The Business Research Company that provides AI in oncology for analytical solutions market statistics, including AI in oncology for analytical solutions industry global market size, regional shares, competitors with a AI in oncology for analytical solutions market share, detailed AI in oncology for analytical solutions market segments, market trends and opportunities, and any further data you may need to thrive in the AI in oncology for analytical solutions industry. This AI in oncology for analytical solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The AI in oncology for analytical solutions market size has grown exponentially in recent years. It will grow from $1.07 billion in 2024 to $1.44 billion in 2025 at a compound annual growth rate (CAGR) of 34.4%. The growth in the historic period can be attributed to increasing healthcare data availability, rising awareness and acceptance, advancements in machine learning algorithms, government initiatives and funding, clinical acceptance.

The AI in oncology for analytical solutions market size is expected to see exponential growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 34.1%. The growth in the forecast period can be attributed to rising demand for personalized medicine, increasing healthcare awareness, integration of multi-omics data, regulatory refinement, telemedicine and remote diagnostics. Major trends in the forecast period include collaborations and partnerships, continuous technological advancements, industry collaborations, research and development initiatives, advancements in technology.

The growing prevalence of cancer is expected to drive the expansion of the AI in oncology for analytical solutions market. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. AI in oncology for analytical solutions plays a significant role in cancer care by enabling personalized treatment, early detection, and improved patient outcomes through its capacity to process large volumes of complex data quickly and efficiently. For example, in May 2024, the National Cancer Institute, a US-based government agency, projected that in 2024, approximately 2 million new cancer cases would be diagnosed in the U.S., with over 611,000 cancer-related deaths. By 2040, new cancer cases globally are expected to rise to 29.9 million, with cancer-related deaths reaching 15.3 million. As a result, the increasing prevalence of cancer is driving the growth of AI in oncology for analytical solutions.

Prominent companies in the AI in oncology for analytical solutions market are focusing on advancing AI technologies, including the development of new real-world data platforms to accelerate cancer research and enhance generative AI models in oncology. A real-world data platform integrates and manages observational data from diverse sources outside of conventional clinical research settings, such as electronic health records, health insurance claims, patient surveys, and disease registries. For instance, in October 2023, the Central Ohio Transit Authority in the US launched Vista, a new real-world data platform designed to expedite cancer research and enhance generative AI models in oncology. Vista integrates multiple databases, including the data portal database and the genomic database, to provide a comprehensive and standardized approach to managing cancer research data. Additionally, Vista is expected to facilitate data sharing, enhance data quality, and support various applications in oncology and other healthcare domains.

In December 2023, ConcertAI, an India-based medical research developer, acquired CancerLinQ, a US-based cancer treatment company specializing in AI-based data and analytics, aiming to establish the leading healthcare learning and research network in oncology. This acquisition seeks to provide members with upgraded quality reporting, industry-leading real-world data, and AI-powered solutions to accelerate clinical trials.

Major companies operating in the AI in oncology for analytical solutions market report are IBM Watson Health, NVIDIA Corporation, Siemens Healthineers, GE Healthcare, Tempus, DeepMind Health, Paige.AI, PathAI, Aidoc, Nucleai, HeartFlow, OWKIN, SOPHiA Genetics, Imagen Technologies, Butterfly Network, Atomwise, Enlitic, Inspirata, 3Scan, Zebra Medical Vision, Ibex Medical Analytics, Vuno Inc., Proscia, Google Health, Huiying Medical

North America was the largest region in the AI In oncology for analytical solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in oncology for analytical solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in oncology for analytical solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The AI in oncology for analytical solutions market consists of revenues earned by entities by providing services such as consulting services, implementation services, training services, medical imaging analysis services, genomic data interpretation services, and drug discovery and development solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in oncology for analytical solutions market also includes sales of AI-powered imaging tools, drug discovery and development devices, and recurrence monitoring systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Oncology For Analytical Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in oncology for analytical solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in oncology for analytical solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in oncology for analytical solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Data Licensing Services; Software Solutions; Analytics and Other Services
• 2) By Treatment Type: Chemotherapy; Radiotherapy; Immunotherapy; Other Treatments
• 3) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Kidney Cancer; Non-Hodgkin Lymphoma; Bladder Cancer
• Subsegments:
• 1) By Data Licensing Services: Oncology Data Licensing; Genomic Data Licensing
• 2) By Software Solutions: AI-Based Imaging Software; Diagnostic Software; Clinical Decision Support Software
• 3) By Analytics And Other Services: Predictive Analytics Services; AI Training And Support Services; Data Analysis Services
• Companies Mentioned: IBM Watson Health; NVIDIA Corporation; Siemens Healthineers; GE Healthcare; Tempus
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Oncology For Analytical Solutions Market Characteristics

3. AI In Oncology For Analytical Solutions Market Trends And Strategies

4. AI In Oncology For Analytical Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global AI In Oncology For Analytical Solutions Growth Analysis And Strategic Analysis Framework

• 5.1. Global AI In Oncology For Analytical Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global AI In Oncology For Analytical Solutions Market Growth Rate Analysis
• 5.4. Global AI In Oncology For Analytical Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global AI In Oncology For Analytical Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global AI In Oncology For Analytical Solutions Total Addressable Market (TAM)

6. AI In Oncology For Analytical Solutions Market Segmentation

• 6.1. Global AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Licensing Services
• Software Solutions
• Analytics and Other Services
• 6.2. Global AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Radiotherapy
• Immunotherapy
• Other Treatments
• 6.3. Global AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Tumor
• Kidney Cancer
• Non-Hodgkin Lymphoma
• Bladder Cancer
• 6.4. Global AI In Oncology For Analytical Solutions Market, Sub-Segmentation Of Data Licensing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology Data Licensing
• Genomic Data Licensing
• 6.5. Global AI In Oncology For Analytical Solutions Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Based Imaging Software
• Diagnostic Software
• Clinical Decision Support Software
• 6.6. Global AI In Oncology For Analytical Solutions Market, Sub-Segmentation Of Analytics And Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Analytics Services
• AI Training And Support Services
• Data Analysis Services

7. AI In Oncology For Analytical Solutions Market Regional And Country Analysis

• 7.1. Global AI In Oncology For Analytical Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global AI In Oncology For Analytical Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Oncology For Analytical Solutions Market

• 8.1. Asia-Pacific AI In Oncology For Analytical Solutions Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Oncology For Analytical Solutions Market

• 9.1. China AI In Oncology For Analytical Solutions Market Overview
• 9.2. China AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Oncology For Analytical Solutions Market

• 10.1. India AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Oncology For Analytical Solutions Market

• 11.1. Japan AI In Oncology For Analytical Solutions Market Overview
• 11.2. Japan AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Oncology For Analytical Solutions Market

• 12.1. Australia AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Oncology For Analytical Solutions Market

• 13.1. Indonesia AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Oncology For Analytical Solutions Market

• 14.1. South Korea AI In Oncology For Analytical Solutions Market Overview
• 14.2. South Korea AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Oncology For Analytical Solutions Market

• 15.1. Western Europe AI In Oncology For Analytical Solutions Market Overview
• 15.2. Western Europe AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Oncology For Analytical Solutions Market

• 16.1. UK AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Oncology For Analytical Solutions Market

• 17.1. Germany AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Oncology For Analytical Solutions Market

• 18.1. France AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Oncology For Analytical Solutions Market

• 19.1. Italy AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Oncology For Analytical Solutions Market

• 20.1. Spain AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Oncology For Analytical Solutions Market

• 21.1. Eastern Europe AI In Oncology For Analytical Solutions Market Overview
• 21.2. Eastern Europe AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Oncology For Analytical Solutions Market

• 22.1. Russia AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Oncology For Analytical Solutions Market

• 23.1. North America AI In Oncology For Analytical Solutions Market Overview
• 23.2. North America AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Oncology For Analytical Solutions Market

• 24.1. USA AI In Oncology For Analytical Solutions Market Overview
• 24.2. USA AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Oncology For Analytical Solutions Market

• 25.1. Canada AI In Oncology For Analytical Solutions Market Overview
• 25.2. Canada AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Oncology For Analytical Solutions Market

• 26.1. South America AI In Oncology For Analytical Solutions Market Overview
• 26.2. South America AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Oncology For Analytical Solutions Market

• 27.1. Brazil AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Oncology For Analytical Solutions Market

• 28.1. Middle East AI In Oncology For Analytical Solutions Market Overview
• 28.2. Middle East AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Oncology For Analytical Solutions Market

• 29.1. Africa AI In Oncology For Analytical Solutions Market Overview
• 29.2. Africa AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Oncology For Analytical Solutions Market Competitive Landscape And Company Profiles

• 30.1. AI In Oncology For Analytical Solutions Market Competitive Landscape
• 30.2. AI In Oncology For Analytical Solutions Market Company Profiles
  • 30.2.1. IBM Watson Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Tempus Overview, Products and Services, Strategy and Financial Analysis

31. AI In Oncology For Analytical Solutions Market Other Major And Innovative Companies

• 31.1. DeepMind Health
• 31.2. Paige.AI
• 31.3. PathAI
• 31.4. Aidoc
• 31.5. Nucleai
• 31.6. HeartFlow
• 31.7. OWKIN
• 31.8. SOPHiA Genetics
• 31.9. Imagen Technologies
• 31.10. Butterfly Network
• 31.11. Atomwise
• 31.12. Enlitic
• 31.13. Inspirata
• 31.14. 3Scan
• 31.15. Zebra Medical Vision

32. Global AI In Oncology For Analytical Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Oncology For Analytical Solutions Market

34. Recent Developments In The AI In Oncology For Analytical Solutions Market

35. AI In Oncology For Analytical Solutions Market High Potential Countries, Segments and Strategies

• 35.1 AI In Oncology For Analytical Solutions Market In 2029 - Countries Offering Most New Opportunities
• 35.2 AI In Oncology For Analytical Solutions Market In 2029 - Segments Offering Most New Opportunities
• 35.3 AI In Oncology For Analytical Solutions Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer